Hit Counter
 RETURN TO INDEX  

FDA did *NOT* raise concerns re SAME risks in Pristique's use as an antidepressant

July 26 2007 at 5:36 PM
admin 


Response to Pristique fails FDA approval as 'menopause pill' - heart & liver risk concerns raised

http://www.boston.com/business/globe/articles/2007/07/25/menopause_pill_by_wyeth_fails_to_get_fda_nod/

"...Wyeth chief medical officer Gary Stiles said the company hasn't been asked to give the FDA more data on Pristiq for depression, and that the delay for menopause symptoms shouldn't influence an FDA action on the other use..."

 

So if there are INDICATIONS OF SERIOUS RISKS in a drug where the manufacturer applies for approval for the menopause -  it warrants the FDA seeking more data and more tests ......

BUT when approval for the VERY SAME DRUG with the same INDICATIONS OF SERIOUS RISK  is sought for use as in the PSYCHIATRIC FIELD, - the FDA just let it pass?

Why is that?

Do the FDA consider that the life of people with depression is not worth protecting?

 

Didn't Hitler's Nazi Germany have a similar view on mental health?  

Its not a huge leap between allowing a drug to go through for mental health which is not deemed safe for any other use in medicine without further studies, and that of exterminating people with mental health problems outright.


 
 Respond to this message   
Get your own free hit counter from SurferStats Counter!